2015
DOI: 10.3390/biom5031652
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy

Abstract: Most chemotherapy regimens contain at least one DNA-damaging agent that preferentially affects the growth of cancer cells. This strategy takes advantage of the differences in cell proliferation between normal and cancer cells. Chemotherapeutic drugs are usually designed to target rapid-dividing cells because sustained proliferation is a common feature of cancer [1,2]. Rapid DNA replication is essential for highly proliferative cells, thus blocking of DNA replication will create numerous mutations and/or chromo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
93
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 112 publications
(93 citation statements)
references
References 116 publications
0
93
0
Order By: Relevance
“…chRFWD3 This is dissimilar to synthetic lethality that affects all cells with deficient HR. Synthetic lethality occurs when there is a potent and lethal synergy between 2 otherwise nonlethal events: in this context, 1 element is camptothecin, a highly specific DNA topoisomerase I inhibitor that acts to maintain single-strand breaks generated by topoisomerases during replication (39), or olaparib, a PARP inhibitor that also blocks repair of DNA single-strand breaks (40). Unrepaired single-strand breaks are converted to doublestrand breaks upon replication.…”
Section: Discussionmentioning
confidence: 99%
“…chRFWD3 This is dissimilar to synthetic lethality that affects all cells with deficient HR. Synthetic lethality occurs when there is a potent and lethal synergy between 2 otherwise nonlethal events: in this context, 1 element is camptothecin, a highly specific DNA topoisomerase I inhibitor that acts to maintain single-strand breaks generated by topoisomerases during replication (39), or olaparib, a PARP inhibitor that also blocks repair of DNA single-strand breaks (40). Unrepaired single-strand breaks are converted to doublestrand breaks upon replication.…”
Section: Discussionmentioning
confidence: 99%
“…PIMI has a known function of regulating cell cycle progression from late G1 through S-phase. In addition, STAG2 , TOP1 , and MAD2L2 were also miRNA targets that are involved in cell cycle processes including formation of the cohesion complex which is necessary for the separation of sister chromatids, alterations of topologic states, and accurate mitosis (Li et al, 2015; Listovsky et al, 2013; Xu et al, 2015). One limitation of the targeting analysis is that the samples analyzed in the current study and in the past transcriptomic analysis was from different biological samples.…”
Section: Discussionmentioning
confidence: 99%
“…inhibitors work by blocking the ligation step of the cell cycle by generating single and double strands breaks which in turn harm the integrity of the genome; the break results to apoptosis cell death [24]. Apparently, TOP1 inhibitors play a great role towards cancer treatment.…”
Section: Introductionmentioning
confidence: 99%